Young people ask their COVID-19 questions to our CEO Mat Shaw

1 May 2020, 4:56 p.m.

Grace, who’s the chair of the GOSH Young People's Forum, has a virtual sit down with our CEO Mat Shaw to get his answers on some of the pressing questions that GOSH patients and siblings would like answered around coronavirus (COVID-19)

It’s really great to know how GOSH are supporting their patients and their families, but also other hospitals and around London too." -- Grace

With the uncertainties around COVID-19, it’s important that questions from children and young people are answered and their worries and concerns addressed. In their 10-minute chat, Grace and Mat go through a series of insightful questions submitted by young people from across GOSH that touch on the following topics:

  • What children and young people can expect coming to GOSH at this time
  • Coronavirus and how it affects children
  • COVID-19 research at GOSH, in collaboration with scientists at the UCL Great Ormond Street Institute of Child Health (ICH) and the Zayed Centre for Research into Rare Disease in Children
  • What COVID-19 means for young people transitioning to another hospital
  • How GOSH staff are being supported and thanked 
Have a listen to their discussion: 

You can find more information about what COVID-19 might mean for you and your family in our general FAQs at www.gosh.nhs.uk/covid-19-FAQ. We’re also sharing the latest news, information and families resources in our COVID-19 information hub at www.gosh.nhs.uk/covid-19.

Surgery in the womb for spina bifida has stopped paralysis in dozens of babies

Dozens of babies with spina bifida have been spared paralysis and other life-limiting conditions after undergoing surgery in the womb in a cutting-edge procedure made available on the NHS.

Get Active: Cancer Sports Day 2021

On 3 July 2021 the GOSH Oncology team's cancer sports day is back, reuniting UCL and GOSH patients past and present with the wide spectrum of GOSH staff involved in their care, including doctors, nurses, physios and dietitians.

Common inflammatory bowel disease treatment is linked to reduced COVID-19 antibody response

New evidence indicates the commonly-prescribed inflammatory bowel disease (IBD) drug infliximab blunts the immune system to COVID-19 infection, potentially increasing the risk of reinfection.

GOSH and Moorfields treat the UK’s youngest patient with sight-saving gene therapy

Three year old Leo and his family appear in BBC 2's DNA Family Secrets to share their journey for answers into his condition and his successful treatment with Voretigene Neparvovec